Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Executive Deputy EditorIndividualAuthor
To the Editor: In a randomized controlled trial
of interleukin 2 (IL-2) in combination with antiretroviral therapy (ART) for
human immunodeficiency virus type 1 (HIV-1) infection, Dr Davey and colleagues1 observed a larger decrease in viral load with IL-2
plus ART compared with ART alone (control arm). The authors suggest that IL-2
was responsible for this better control of viral load.
Aboulker J. Viral Load in Treatment With Antiretroviral Therapy and Interleukin 2. JAMA. 2000;284(16):2055-2056. doi:10.1001/jama.284.16.2053